Wegovy Approved: EU OKs 7.2mg Weekly Dose for Weight Management
Berlin, Germany – February 21, 2026 – The European Commission has approved a higher 7.2 mg dose of the injectable medication Wegovy (semaglutide) for adults with obesity, expanding treatment options for a growing public health concern. This approval provides a new once-weekly maintenance dose, offering a potentially more effective tool in managing weight and related … Read more